UNISUN
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 27 Mar 2023)
What this means for you
Registered since 28 Jun 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86383810
- Registration number
- 4989255
- Mark type
- Stylized text
- Filed
- 03 Sept 2014
- Published for opposition
- 29 Dec 2015
- Registered
- 28 Jun 2016
- Attorney of record
- C. Blair Barbieri
Goods and services
- Class 040 — Treatment of materials: Manufacturing services for others in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, clinical manufacturing of drug formulations for others to support clinical trials, fabrication and preparation of active pharmaceutical ingredients for others, technology scale-up services for others, and integration of technology into manufacturing processes for others, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for inner ear delivery
- Class 042 — Scientific and technological services: Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredients, analytic techniques to test drug formulations, analytic services to detect, identify and quantify drug components, stability testing, physical characterization of drug formulations, in-vitro release testing, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for inner ear delivery
Owner
- Adare Pharmaceuticals Usa, Inc., Philadelphia, PA, US
- Orbis Biosciences, Inc., Lenexa, KS, US
- Orbis Biosciences, Inc., Lenexa, KS, US
- Orbis Biosciences, Inc., Kansas City, KS, US
Prosecution history
- 28 Jun 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 14 Feb 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 14 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 14 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 Mar 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 27 Mar 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 15 Feb 2023 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 04 Oct 2022 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 04 Oct 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Apr 2022 — TEAS SECTION 8 & 15 RECEIVED
- 28 Jun 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Oct 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY